BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Varrone F, Caputo E. The miRNAs Role in Melanoma and in Its Resistance to Therapy. Int J Mol Sci 2020;21:E878. [PMID: 32013263 DOI: 10.3390/ijms21030878] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang W, Mao K, Liu S, Xu Y, Ren J. miR-942-5p promotes the proliferation and invasion of human melanoma cells by targeting DKK3. J Recept Signal Transduct Res 2021;41:180-7. [PMID: 32772782 DOI: 10.1080/10799893.2020.1804280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Gebhardt K, Edemir B, Groß E, Nemetschke L, Kewitz-Hempel S, Moritz RKC, Sunderkötter C, Gerloff D. BRAF/EZH2 Signaling Represses miR-129-5p Inhibition of SOX4 Thereby Modulating BRAFi Resistance in Melanoma. Cancers (Basel) 2021;13:2393. [PMID: 34063443 DOI: 10.3390/cancers13102393] [Reference Citation Analysis]
3 Bustos MA, Gross R, Rahimzadeh N, Cole H, Tran LT, Tran KD, Takeshima L, Stern SL, O'Day S, Hoon DSB. A Pilot Study Comparing the Efficacy of Lactate Dehydrogenase Levels Versus Circulating Cell-Free microRNAs in Monitoring Responses to Checkpoint Inhibitor Immunotherapy in Metastatic Melanoma Patients. Cancers (Basel) 2020;12:E3361. [PMID: 33202891 DOI: 10.3390/cancers12113361] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Fattore L, Ruggiero CF, Liguoro D, Castaldo V, Catizone A, Ciliberto G, Mancini R. The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma. Front Oncol 2021;11:645069. [PMID: 33816298 DOI: 10.3389/fonc.2021.645069] [Reference Citation Analysis]
5 Wang X, Cui Z, Zeng B, Qiong Z, Long Z. Human mesenchymal stem cell derived exosomes inhibit the survival of human melanoma cells through modulating miR-138-5p/SOX4 pathway. Cancer Biomark 2022. [PMID: 35275523 DOI: 10.3233/CBM-210409] [Reference Citation Analysis]
6 Varrone F, Mandrich L, Caputo E. Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going? Cancers (Basel) 2021;13:5788. [PMID: 34830940 DOI: 10.3390/cancers13225788] [Reference Citation Analysis]
7 Ghafouri-Fard S, Gholipour M, Taheri M. MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets. Front Oncol 2021;11:608987. [PMID: 33968718 DOI: 10.3389/fonc.2021.608987] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Melnik BC, John SM, Carrera-Bastos P, Schmitz G. MicroRNA-21-Enriched Exosomes as Epigenetic Regulators in Melanomagenesis and Melanoma Progression: The Impact of Western Lifestyle Factors. Cancers (Basel) 2020;12:E2111. [PMID: 32751207 DOI: 10.3390/cancers12082111] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
9 Lazăr AD, Dinescu S, Costache M. The Non-Coding Landscape of Cutaneous Malignant Melanoma: A Possible Route to Efficient Targeted Therapy. Cancers (Basel) 2020;12:E3378. [PMID: 33203119 DOI: 10.3390/cancers12113378] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Hushcha Y, Blo I, Oton-Gonzalez L, Mauro GD, Martini F, Tognon M, Mattei M. microRNAs in the Regulation of Melanogenesis. Int J Mol Sci 2021;22:6104. [PMID: 34198907 DOI: 10.3390/ijms22116104] [Reference Citation Analysis]
11 Scatena C, Murtas D, Tomei S. Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies. Front Oncol 2021;11:635488. [PMID: 34123788 DOI: 10.3389/fonc.2021.635488] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Vandyck HH, Hillen LM, Bosisio FM, van den Oord J, Zur Hausen A, Winnepenninckx V. Rethinking the biology of metastatic melanoma: a holistic approach. Cancer Metastasis Rev 2021;40:603-24. [PMID: 33870460 DOI: 10.1007/s10555-021-09960-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Li Y, Ye Z, Yang W, Zhang Q, Zeng J. An Update on the Potential of Mesenchymal Stem Cell Therapy for Cutaneous Diseases. Stem Cells Int 2021;2021:8834590. [PMID: 33505474 DOI: 10.1155/2021/8834590] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Welsh M. The Felicitous Success of the Subsection Molecular Oncology of International Journal of Molecular Sciences. Int J Mol Sci 2021;22:6939. [PMID: 34203257 DOI: 10.3390/ijms22136939] [Reference Citation Analysis]
15 Yang F, Lei P, Zeng W, Gao J, Wu N. Long Noncoding RNA LINC00173 Promotes the Malignancy of Melanoma by Promoting the Expression of IRS4 Through Competitive Binding to microRNA-493. Cancer Manag Res 2020;12:3131-44. [PMID: 32440211 DOI: 10.2147/CMAR.S243869] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
16 Yang T, Wei L, Ma X, Ke H. Columbamine suppresses proliferation and invasion of melanoma cell A375 via HSP90-mediated STAT3 activation. J Recept Signal Transduct Res 2021;41:99-104. [PMID: 32669028 DOI: 10.1080/10799893.2020.1794003] [Reference Citation Analysis]
17 Gong Q, Yu H, Ding G, Ma J, Wang Y, Cheng X. Suppression of stemness and enhancement of chemosensibility in the resistant melanoma were induced by Astragalus polysaccharide through PD-L1 downregulation. Eur J Pharmacol 2021;916:174726. [PMID: 34954232 DOI: 10.1016/j.ejphar.2021.174726] [Reference Citation Analysis]
18 Diana A, Gaido G, Maxia C, Murtas D. MicroRNAs at the Crossroad of the Dichotomic Pathway Cell Death vs. Stemness in Neural Somatic and Cancer Stem Cells: Implications and Therapeutic Strategies. Int J Mol Sci 2020;21:E9630. [PMID: 33348804 DOI: 10.3390/ijms21249630] [Reference Citation Analysis]